Bank of Kentucky’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
Other funds holding CASC
BI
QF
GPP
BIT
DM
BFA
BC
HCMT
Bank of Kentucky's CASC Position: Q3 2014 in Review
Bank of Kentucky sold out of Cascadian Therapeutics, Inc. (CASC) in Q3 2014, closing a stake of 56 shares — an estimated $1K sold.
Bank of Kentucky first reported a position in CASC in Q2 2014 and held it in 1 quarter. The position peaked at $1K in Q2 2014. 86 funds tracked by Wall St. Rank hold CASC as of Q3 2014.
- Bank of Kentucky reported no remaining Cascadian Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
- Bank of Kentucky sold 56 Cascadian Therapeutics, Inc. shares in Q3 2014, an estimated $1K.
- Bank of Kentucky first reported a position in Cascadian Therapeutics, Inc. in Q2 2014 and held it in 1 quarter.
- Bank of Kentucky's Cascadian Therapeutics, Inc. position peaked at $1K in Q2 2014.
- 86 funds tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q3 2014.
Based on Bank of Kentucky's 13F filing for Q3 2014, filed 14 Nov 2014.